BLOG
EmeTerm Wristband Significantly Reduction in Po...
VANCOUVER, BC, November 3rd, 2025 /PRNewswire/ — WAT Medical Enterprise Ltd. proudly announced the publication of a groundbreaking clinical trial in The Journal of Bone & Joint Surgery (JBJS) which demonstrates the significant benefits...
EmeTerm Wristband Significantly Reduction in Po...
VANCOUVER, BC, November 3rd, 2025 /PRNewswire/ — WAT Medical Enterprise Ltd. proudly announced the publication of a groundbreaking clinical trial in The Journal of Bone & Joint Surgery (JBJS) which demonstrates the significant benefits...
EmeTerm Wearable Device Under Clinical Study at...
VANCOUVER, BC, September 15, 2025 /PRNewswire/ – WAT Medical Enterprise Ltd. is proud to announce that its innovative anti-nausea wristband, EmeTerm, has made significant progress in alleviating nausea and vomiting among...
EmeTerm Wearable Device Under Clinical Study at...
VANCOUVER, BC, September 15, 2025 /PRNewswire/ – WAT Medical Enterprise Ltd. is proud to announce that its innovative anti-nausea wristband, EmeTerm, has made significant progress in alleviating nausea and vomiting among...
American Migraine Foundation Highlights HeadaTe...
VANCOUVER, BC, June 16, 2025 /PRNewswire/ — WAT Medical Enterprise Ltd. is pleased to announce that its migraine relief device, HeadaTerm 2, is now featured on the American Migraine Foundation’s (AMF)...
American Migraine Foundation Highlights HeadaTe...
VANCOUVER, BC, June 16, 2025 /PRNewswire/ — WAT Medical Enterprise Ltd. is pleased to announce that its migraine relief device, HeadaTerm 2, is now featured on the American Migraine Foundation’s (AMF)...
Neuromodulation Wristband ObeEnd Reduces Heart ...
VANCOUVER, BC, Jan.13, 2025 /PRNewswire/ —WAT Medical Enterprise collaborated with Concordia University and Mitacs Canada to conduct a study using ObeEnd, the neuromodulation device designed for weight and health management. The study revealed...
Neuromodulation Wristband ObeEnd Reduces Heart ...
VANCOUVER, BC, Jan.13, 2025 /PRNewswire/ —WAT Medical Enterprise collaborated with Concordia University and Mitacs Canada to conduct a study using ObeEnd, the neuromodulation device designed for weight and health management. The study revealed...
WAT Medical Sponsors American Headache Society ...
VANCOUVER, BC, Dec. 9, 2024 /PRNewswire/ — WAT Medical Enterprise proudly sponsored the 2024 Scottsdale Headache Symposium, organized by the American Headache Society from November 14-17 in Scottsdale, AZ. This annual event brought together a multidisciplinary...
WAT Medical Sponsors American Headache Society ...
VANCOUVER, BC, Dec. 9, 2024 /PRNewswire/ — WAT Medical Enterprise proudly sponsored the 2024 Scottsdale Headache Symposium, organized by the American Headache Society from November 14-17 in Scottsdale, AZ. This annual event brought together a multidisciplinary...
EmeTerm Smart and HeadaTerm 2 Achieve Health Ca...
VANCOUVER, BC, Oct. 16, 2024 /PRNewswire/ -- WAT Medical Enterprise proudly announces a significant achievement: both EmeTerm Smart and HeadaTerm 2 have received Medical Device Licences (MDL) from Health Canada. EmeTerm Smart...
EmeTerm Smart and HeadaTerm 2 Achieve Health Ca...
VANCOUVER, BC, Oct. 16, 2024 /PRNewswire/ -- WAT Medical Enterprise proudly announces a significant achievement: both EmeTerm Smart and HeadaTerm 2 have received Medical Device Licences (MDL) from Health Canada. EmeTerm Smart...